UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Advances in anatomic pathology, ISSN 1072-4109, 11/2017, Volume 24, Issue 6, pp. 311 - 335
Life Sciences & Biomedicine | Pathology | Science & Technology | Immunohistochemistry | Mesothelioma - immunology | Predictive Value of Tests | Mesothelioma - pathology | Carcinoma, Squamous Cell - pathology | Humans | Brain Neoplasms - pathology | Ovarian Neoplasms - pathology | Lung Neoplasms - pathology | Pathology - standards | Gastrointestinal Neoplasms - pathology | Endometrial Neoplasms - immunology | Squamous Cell Carcinoma of Head and Neck | Brain Neoplasms - immunology | Female | Carcinoma, Non-Small-Cell Lung - pathology | Skin Neoplasms - pathology | Skin Neoplasms - immunology | Biomarkers, Tumor - analysis | Urogenital Neoplasms - pathology | Melanoma - pathology | Carcinoma, Squamous Cell - immunology | Head and Neck Neoplasms - pathology | Urogenital Neoplasms - immunology | Carcinoma, Non-Small-Cell Lung - immunology | Gastrointestinal Neoplasms - immunology | Head and Neck Neoplasms - immunology | Lung Neoplasms - immunology | Phenotype | Lymphocytes, Tumor-Infiltrating - pathology | Biopsy | Melanoma - immunology | Endometrial Neoplasms - pathology | Pathology - methods | Lymphocytes, Tumor-Infiltrating - immunology | Ovarian Neoplasms - immunology | Biomarkers | Lymphocytes | Immunotherapy | tumor-infiltrating | Cancer
Journal Article
2007, IARC monographs on the evaluation of carcinogenic risks to humans, ISBN 9283212908, Volume 90, viii, 670
Book
Journal of clinical oncology, ISSN 0732-183X, 12/2015, Volume 33, Issue 34, pp. 4015 - 4022
Life Sciences & Biomedicine | Oncology | Science & Technology | Prognosis | Follow-Up Studies | Endometrial Neoplasms - mortality | Adenocarcinoma, Clear Cell - mortality | Humans | Middle Aged | Ovarian Neoplasms - pathology | Salvage Therapy | Neoplasm Recurrence, Local - drug therapy | Antibodies, Monoclonal - therapeutic use | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Ovarian Neoplasms - mortality | Neoplasm Recurrence, Local - mortality | Cystadenocarcinoma, Serous - drug therapy | Neoplasm Recurrence, Local - pathology | Peritoneal Neoplasms - drug therapy | Female | Ovarian Neoplasms - drug therapy | Platinum - pharmacology | Peritoneal Neoplasms - secondary | Cystadenocarcinoma, Serous - secondary | Neoplasm Invasiveness | Survival Rate | Lymphatic Metastasis | Peritoneal Neoplasms - mortality | Endometrial Neoplasms - secondary | Adenocarcinoma, Clear Cell - secondary | Cystadenocarcinoma, Serous - mortality | Endometrial Neoplasms - drug therapy | Aged | Programmed Cell Death 1 Receptor - immunology | Neoplasm Staging | Adenocarcinoma, Clear Cell - drug therapy | Cohort Studies | Drug Resistance, Neoplasm - drug effects | Index Medicus
Journal Article
The Journal of pathology, ISSN 0022-3417, 2018, Volume 245, Issue 3, pp. 283 - 296
endometrial cancer | mutation | colorectal cancer | POLE | precursor lesion | polymerase proofreading | Pathology | Oncology | Life Sciences & Biomedicine | Science & Technology | Genomic Instability | Adenocarcinoma - pathology | Poly-ADP-Ribose Binding Proteins - metabolism | Colorectal Neoplasms - genetics | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Databases, Genetic | Tumor Microenvironment | Male | DNA Polymerase II - metabolism | Endometrial Neoplasms - immunology | Neoplasm Grading | Endometrial Neoplasms - genetics | Cell Transformation, Neoplastic - genetics | Antigens, Neoplasm - metabolism | CD8-Positive T-Lymphocytes - metabolism | Female | Lymphocytes, Tumor-Infiltrating - metabolism | Adenocarcinoma - genetics | DNA Polymerase II - genetics | Antigens, Neoplasm - genetics | Colorectal Neoplasms - enzymology | Genetic Predisposition to Disease | Endometrial Neoplasms - enzymology | Antigens, Neoplasm - immunology | Adenocarcinoma - immunology | Adenocarcinoma - enzymology | Poly-ADP-Ribose Binding Proteins - genetics | Gene Expression Profiling - methods | Cell Transformation, Neoplastic - metabolism | Whole Genome Sequencing | Cell Transformation, Neoplastic - immunology | Phenotype | Colorectal Neoplasms - immunology | Endometrial Neoplasms - pathology | Mutation | CD8-Positive T-Lymphocytes - immunology | Cell Transformation, Neoplastic - pathology | Colorectal Neoplasms - pathology | Neoplasm Staging | Lymphocytes, Tumor-Infiltrating - immunology | Genetic aspects | Immune response | Carcinogenesis | Tumor antigens | Prognosis | Stability | Initiators | CD8 antigen | p53 Protein | Colorectal carcinoma | Lymphocytes T | Genomes | Molecular chains | Gene sequencing | Genomic instability | Carcinogens | Exonuclease | Precursors | Tumorigenesis | Lesions | Endometrium | Cancer | Tumors | Immune system | Index Medicus | Original Papers | Original Paper
Journal Article
Anticancer research, ISSN 0250-7005, 08/2009, Volume 29, Issue 8, pp. 2875 - 2884
Cell mediated immunity | Cytokines | Ascites | Chemokines | Ovarian cancer | Gynecology. Andrology. Obstetrics | Biological and medical sciences | Medical sciences | Tumors | Female genital diseases | CD8-Positive T-Lymphocytes - pathology | Prognosis | Humans | Middle Aged | Cystadenocarcinoma, Serous - metabolism | Endometrial Neoplasms - metabolism | Ovarian Neoplasms - pathology | CD4-Positive T-Lymphocytes - pathology | Adenocarcinoma, Clear Cell - immunology | T-Lymphocytes, Regulatory - immunology | CD4-Positive T-Lymphocytes - immunology | Antigen-Presenting Cells - pathology | Endometrial Neoplasms - immunology | Flow Cytometry | Fallopian Tube Neoplasms - immunology | Aged, 80 and over | Ascites - immunology | CD8-Positive T-Lymphocytes - metabolism | Adult | Female | Ovarian Neoplasms - metabolism | Cystadenocarcinoma, Serous - immunology | Peritoneal Neoplasms - immunology | Peritoneal Neoplasms - pathology | Cystadenocarcinoma, Serous - secondary | Antigen-Presenting Cells - metabolism | Cytokines - metabolism | Adenocarcinoma, Clear Cell - metabolism | CD4-Positive T-Lymphocytes - metabolism | Fallopian Tube Neoplasms - pathology | Survival Rate | Chromium - metabolism | Antigen-Presenting Cells - immunology | Endometrial Neoplasms - secondary | Adenocarcinoma, Clear Cell - secondary | Ascites - metabolism | Peritoneal Neoplasms - metabolism | Aged | Fallopian Tube Neoplasms - metabolism | CD8-Positive T-Lymphocytes - immunology | Ascites - pathology | Ovarian Neoplasms - immunology | Index Medicus
Journal Article
Clinical cancer research, ISSN 1078-0432, 08/2017, Volume 23, Issue 15, pp. 4473 - 4481
Life Sciences & Biomedicine | Oncology | Science & Technology | Microsatellite Instability | CD8-Positive T-Lymphocytes - pathology | Colorectal Neoplasms - genetics | Colorectal Neoplasms, Hereditary Nonpolyposis - genetics | Colorectal Neoplasms, Hereditary Nonpolyposis - pathology | Humans | Middle Aged | Colorectal Neoplasms, Hereditary Nonpolyposis - immunology | Endometrial Neoplasms - diagnosis | Colorectal Neoplasms - diagnosis | Microsatellite Repeats - genetics | Tumor Microenvironment - immunology | Endometrial Neoplasms - immunology | Colorectal Neoplasms - immunology | Tumor Microenvironment - genetics | Endometrial Neoplasms - genetics | Colorectal Neoplasms, Hereditary Nonpolyposis - diagnosis | Immunotherapy | Endometrial Neoplasms - pathology | Female | Aged | CD8-Positive T-Lymphocytes - immunology | Colorectal Neoplasms - pathology | Multiplexing | Populations | Endometrial cancer | CD8 antigen | Clinical trials | Fluorescence | Microsatellite instability | Macrophages | Metastases | Granzyme B | Compartments | Endometrium | Immune system | Medical research | Immune response | Stability | Stroma | Immunogenicity | Lymphocytes B | Experimental design | PD-L1 protein | Infiltration | Hormone replacement therapy | Health risk assessment | Tumors | Cancer | Index Medicus | microsatellite instability | immune microenvironment | Uterine cancer | hereditary cancers | Lynch syndrome
Journal Article
Cancer treatment reviews, ISSN 0305-7372, 09/2017, Volume 59, pp. 109 - 116
PD1/PD-L1 | Endometrial cancer | Immunotherapy | Cervical cancer | Ovarian cancer | Life Sciences & Biomedicine | Oncology | Science & Technology | Immunotherapy - methods | Antibodies, Monoclonal, Humanized - therapeutic use | Prognosis | Risk Assessment | Endometrial Neoplasms - mortality | Humans | Middle Aged | Uterine Cervical Neoplasms - immunology | Uterine Cervical Neoplasms - drug therapy | Uterine Cervical Neoplasms - pathology | Ovarian Neoplasms - mortality | Disease-Free Survival | Endometrial Neoplasms - immunology | Survival Analysis | Endometrial Neoplasms - therapy | Adult | Endometrial Neoplasms - pathology | Female | Aged | Ovarian Neoplasms - drug therapy | Uterine Cervical Neoplasms - mortality | Ovarian Neoplasms - immunology | Medical colleges | Chemotherapy | Vaccination | Diagnosis | Health aspects | Papillomavirus infections | Cancer | Index Medicus
Journal Article
British journal of cancer, ISSN 0007-0920, 01/2019, Volume 120, Issue 1, pp. 115 - 127
Life Sciences & Biomedicine | Oncology | Science & Technology | Humans | Ovarian Neoplasms - pathology | CD4-Positive T-Lymphocytes - immunology | Ovarian Neoplasms - genetics | Tumor Microenvironment - immunology | Endometrial Neoplasms - immunology | Lymphocyte Activation - genetics | Lymphocyte Activation - immunology | Animals | Tumor Microenvironment - genetics | Endometrial Neoplasms - genetics | B7 Antigens - genetics | Immunotherapy | Endometrial Neoplasms - pathology | Female | T-Lymphocytes - immunology | Mice | CD8-Positive T-Lymphocytes - immunology | Ovarian Neoplasms - immunology | Index Medicus | Tumour immunology | Gynaecological cancer
Journal Article